Lynn Seely's Net Worth
$36.1 Million
Who is Lynn Seely?
Lynn Seely has an estimated net worth of $36.1 Million. This is based on reported shares across multiple companies, which include Myovant Sciences Ltd., Blueprint Medicines Corp, Lyell Immunopharma, Inc., and MEDIVATION, INC..
SEC CIK
Lynn Seely's CIK is 0001327111
Past Insider Trading and Trends
2014 was Lynn Seely's most active year for acquiring shares with 24 total transactions. Lynn Seely's most active month to acquire stocks was the month of May. 2014 was Lynn Seely's most active year for disposing of shares, totalling 52 transactions. Lynn Seely's most active month to dispose stocks was the month of August. 2012 saw Lynn Seely paying a total of $3,597,675.00 for 262,500 shares, this is the most they've acquired in one year. In 2012 Lynn Seely cashed out on 384,955 shares for a total of $17,431,187.10, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Myovant Sciences Ltd. No price found
Principal Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +23.36% | 197.66K |
—
|
—
| 1.04M |
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16
| |||
Form 4
| +50.00% | 564.11K |
—
|
—
| 1.69M |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Blueprint Medicines Corp (BPMC) Snapshot price: $86.43
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +20.36% | 2.24K |
—
|
—
| 13.25K |
Jun 12
| |||
Form 4
| +30.91% | 2.6K |
—
|
—
| 11.01K |
Jun 21
| |||
Form 4
| +44.74% | 2.6K |
—
|
—
| 8.41K |
Jun 21
| |||
Form 4
| +63.17% | 2.25K |
—
|
—
| 5.81K |
Jun 2
| |||
Form 4
| +171.49% | 2.25K |
—
|
—
| 3.56K |
Jun 24
| |||
Form 4
|
∞
| 1.31K |
—
|
—
| 1.31K |
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Lyell Immunopharma, Inc. (LYEL) Snapshot price: $1.2
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 200K |
—
|
—
| 200K |
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
MEDIVATION, INC. No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
| +6.03% | 5.5K |
—
|
—
| 96.69K |
Feb 9
| |||
Form 4
| +52.36% | 31.34K |
$10.18 | $318,949.10 | 91.19K |
Dec 19
| |||
Form 4
|
—
|
0
|
$54.81 | -$442,216.50 | 59.85K |
Scheduled
|
Oct 22
| ||
Form 4
|
—
|
0
|
$49.19 | -$2,391,550.51 | 59.85K |
Oct 15 - Oct 16
| |||
Form 4
|
—
|
0
|
$53.95 | -$4,897,460.00 | 59.02K |
Scheduled
|
Sep 17 - Sep 18
| ||
Form 4
|
—
|
0
|
$52.60 | -$1,680,315.94 | 59.02K |
Scheduled
|
Sep 9
| ||
Form 4
|
—
|
0
|
$50.01 | -$1,576,755.10 | 59.02K |
Scheduled
|
Aug 26 - Aug 27
| ||
Form 4
|
—
|
0
|
$46.01 | -$1,504,631.00 | 59.02K |
Scheduled
|
Aug 13
| ||
Form 4
|
—
|
0
|
$46.21 | -$1,877,628.50 | 59.02K |
Scheduled
|
Aug 8 - Aug 12
| ||
Form 4
|
—
|
0
|
$40.35 | -$504,197.25 | 59.02K |
Scheduled
|
Jul 22
| ||
Form 4
|
—
|
0
|
$44.21 | -$835,574.40 | 59.02K |
Scheduled
|
Jul 2
| ||
Form 4
|
—
|
0
|
$40.74 | -$1,020,265.00 | 59.02K |
Scheduled
|
Jun 3 - Jun 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
| +13.46% | 7K |
—
|
—
| 59.02K |
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 4
| +20.92% | 9K |
—
|
—
| 52.02K |
Dec 7
| |||
Form 4
|
—
|
0
|
$67.10 | -$2,602,634.08 | 21.51K |
Scheduled
|
Jul 26 - Jul 26
| ||
Form 4
|
—
|
0
|
$50.99 | -$937,958.75 | 21.51K |
Scheduled
|
May 22
| ||
Form 4
|
—
|
0
|
$54.59 | -$959,828.14 | 21.51K |
Scheduled
|
May 17
| ||
Form 4
|
—
|
0
|
$54.63 | -$2,384,529.84 | 21.51K |
Scheduled
|
May 14
| ||
Form 4
| -20.52% | -5.55K |
$40.24 | -$6,948,561.28 | 21.51K |
Scheduled
|
Mar 8
| ||
Form 4
| +62.40% | 10.4K |
—
|
—
| 27.07K |
Dec 9
| |||
Form 4
|
—
|
0
|
$10.04 | -$643,885.00 | 16.67K |
Scheduled
|
Mar 15
| ||
Form 4
|
—
|
0
|
$10.79 | -$718,320.00 | 16.67K |
Scheduled
|
Feb 15
| ||
Form 4
|
—
|
0
|
$9.31 | -$570,952.50 | 16.67K |
Scheduled
|
Jan 18 - Jan 19
| ||
Form 4
|
∞
| 16.67K |
—
|
—
| 16.67K |
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
$18.44 | -$534,060.00 |
0
|
Scheduled
|
Dec 7
| ||
Form 4
|
—
|
0
|
$14.74 | -$400,791.70 |
0
|
Scheduled
|
Sep 9 - Sep 10
| ||
Form 4
|
—
|
0
|
$12.99 | -$337,795.80 |
0
|
Scheduled
|
Jun 30 - Jul 1
| ||
Form 4
|
—
|
0
|
$10.12 | -$234,652.80 |
0
|
Scheduled
|
Mar 18
| ||
Form 4
|
—
|
0
|
$8.88 | -$95,009.61 |
0
|
Scheduled
|
Dec 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
$16.59 | -$233,717.40 |
0
|
Scheduled
|
Sep 25
| ||
Form 4
|
—
|
0
|
$9.27 | -$102,025.80 |
0
|
Scheduled
|
Jun 9
| ||
Form 4
|
—
|
0
|
$9.62 | -$108,321.30 |
0
|
Scheduled
|
Mar 3
| ||
Form 4
|
—
|
0
|
$8.36 | -$85,554.00 |
0
|
Scheduled
|
Dec 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
$11.27 | -$138,060.00 |
0
|
Scheduled
|
Sep 19
| ||
Form 4
|
—
|
0
|
$10.15 | -$117,891.00 |
0
|
Scheduled
|
Jun 5
| ||
Form 4
|
—
|
0
|
$10.70 | -$127,800.00 |
0
|
Scheduled
|
Mar 16
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |